Search Results - "Holeckova, Klaudia Hives"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer by Híveš, Márk, Jurečeková, Jana, Kliment, Ján, Grendár, Marián, Kaplán, Peter, Dušenka, Róbert, Evin, Daniel, Vilčková, Marta, Holečková, Klaudia Híveš, Sivoňová, Monika Kmeťová

    Published in Cancer genomics & proteomics (01-05-2022)
    “…Background/Aim: Our aim was to investigate possible influences of genetic variants in genes involved in the G1/S transition [cyclin-dependent kinase-2 (CDK2),…”
    Get full text
    Journal Article
  2. 2

    Genetic Variations in TP53, RB1 , and PTEN in a Selected Sample of Slovak Patients With Metastatic Castration-resistant Prostate Cancer by Holeckova, Klaudia Hives, Hives, Mark, Grendar, Marian, Drobkova, Henrieta Blahusiak, Kliment, Sr, Jan

    Published in In vivo (Athens) (01-11-2024)
    “…This report aimed to present identified variants with pathogenic potential in three genes - TP53, PTEN, and RB1 - in a selected sample of patients with…”
    Get full text
    Journal Article
  3. 3

    The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors by Hives, Mark, Jurecekova, Jana, Holeckova, Klaudia Hives, Kliment, Jan, Sivonova, Monika Kmetova

    Published in Bratislavské lékarské listy (01-01-2023)
    “…The cell cycle covers cell proliferation and growth and is strictly regulated by cyclin-dependent kinase, cyclins and their inhibitors. Cyclin-dependent…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Role of Genetic Variations in CDK2 , CCNE1 and p27 KIP1 in Prostate Cancer by Híveš, Márk, Jurečeková, Jana, Kliment, Ján, Grendár, Marián, Kaplán, Peter, Dušenka, Róbert, Evin, Daniel, Vilčková, Marta, Holečková, Klaudia Híveš, Sivoňová, Monika Kmeťová

    Published in Cancer genomics & proteomics (01-05-2022)
    “…Our aim was to investigate possible influences of genetic variants in genes involved in the G /S transition [cyclin-dependent kinase-2 (CDK2), cyclin E1…”
    Get more information
    Journal Article